VEGFA and atrophic macular degeneration: In contrast, real-world settings involve a large and diverse group of patients with nAMD who may present additional manifestations of the disease at different stages (such as drusen, macular scarring, or geographic atrophy) and have confounding diseases or prior/concurrent/adjunctive treatment (such as other anti-VEGF agents, photocoagulation, or photodynamic therapy).